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The regulatory functions of glycosaminoglycan hyaluronan (HA) are suggested to be dependent on its molecular weight (MW).
Proinﬂammatory and stimulatory eﬀects are proposed mainly for the low MW HA. However, the complex response of blood
phagocytes to HA of diﬀerent MW is unclear. Herein, the eﬀects of highly puriﬁed HA of precisely deﬁned MW (52, 250, and
970kDa)onhumanbloodphagocytes were tested. AllMW HAactivated bloodphagocytes, includingthespontaneousproduction
of ROS, degranulation, and the production of tumor necrosis factor alpha, with low MW HA 52kDa having the highest potency
and high MW HA 970kDa having the lowest potency. Interestingly, HA inhibited ROS production stimulated by opsonized
zymosan particles and, in contrast, potentiated starch-activated ROS production, mostly independent of MW. Data showed a
signiﬁcanteﬀect of HA of diﬀerent MW on blood phagocytes, including high MW HA.
1.Introduction
Inﬂammation is a complex process underlying the patho-
genesis of numerous chronic and acute diseases. Intensive
tissue remodeling occurs at the site of inﬂammation. The
extracellular matrix is degraded and replaced by a newly
synthesized onethatcontributestothetissuehealingprocess.
One of the main components of the extracellular matrix is
hyaluronan (HA). HA in its native form is a high-molecular-
weight (HMW) linear glycosaminoglycan reaching a size
of 6 to 8MDa [1–3]. HA binding at the cell surface is a
complex interaction of multivalent binding events aﬀected
mainly by the quantity, density, and activation state of cell
surface HAreceptors, includingCD44andToll-likereceptors
2a n d4[ 2, 4–6]. HA undergoes intensive metabolism
in the organism dependent on tissue [7]. In particular,
inﬂammation signiﬁcantly increases HA degradation to low-
molecular-weight (LMW) fragments. Despite their simple
primary structure, HA molecules have been reported to have
extraordinarily wide-ranging and often opposing biological
functions [2, 3]. HMW HA is widely reported to possess
antiangiogenic, anti-inﬂammatory, and immunosuppressive
properties. On the other hand, smaller fragments of HA
polymers (LMW HA) are believed to be proinﬂammatory
and angiogenic [1, 6].
Among the most important cells in the inﬂamma-
tory process are phagocytes that include tissue-speciﬁc
macrophages and polymorphonuclear leukocytes (PMNL),
particularly neutrophil granulocytes [8]. Phagocytes play a
criticalroleincontrollingacuteandchronictissueinﬂamma-
tion, through the release of a variety of mediators, including
cytokines, chemokines, growth factors, and reactive oxygen
species (ROS) [8–10]. ROS production by phagocytes is
connected with the so-called “oxidative burst,” which is
a key process against invading pathogens [8, 10]. The
oxidative burst is closely related with degranulation of
blood phagocytes accompanied by an increase in surface
receptorexpression[11].Thus,theROSproductionbyblood
phagocytes and the surface expression of receptors allow us
todeterminephagocyteactivationinducedbyvariousstimuli
and to predict physiological consequences of the activation
[11–13].
In general, there is a suggested stimulatory eﬀect of
LMW HA and an inhibitory eﬀect of HMW HA on blood2 Mediators of Inﬂammation
phagocytes, similar to other cell types [14]. In diﬀerent
studies, various authors evaluated the eﬀect of HA on
blood phagocyte functions, particularly phagocytosis [15–
20]. However, a detailed description of blood phagocyte
response to HA of diﬀerent MW in complex environment
of whole blood is absent. Furthermore, the current data
are often contradictory, dependent on the employed model
system and the selected MW HA. The main question raised
by many of these previous studies is the origin and purity of
the HA preparations used.
In the present study, the potential of HMW HA
(970kDa), middle-sized MW (250kDa), and LMW HA
(52kDa) to activate blood phagocytes was tested in vitro.
In contrast to other studies, we used highly puriﬁed HA of
a pharmacological grade with a low polydispersity index.
Phagocyte activity was evaluatedbased on the determination
of the ROS production, the degranulation, and the pro-
duction of tumor necrosis factor alpha. Eﬀects of selected
MW of HA were also tested in the presence of collagen,
as an abundant component of the extracellular matrix
in tissue. Interestingly, all MW HA increased the overall
activation of blood phagocytes. In addition, HA inhibited
ROS production stimulated by opsonized zymosan particles
(OZP), which was in contrast to the potentiation of starch-
activated ROS production by HA. In general, our data
provide information about the role of HA in the activation
of blood phagocytes.
2.Materialsand Methods
2.1. HA Preparation. HA of Streptococcus equi biotechno-
logical origin and pharmaceutical grade (Contipro C, Dolni
Dobrouc, Czech Republic) was used [21]. To prepare HA of
a particular molecular weight (MW), 1% water solution of
0.97–2.33MDaHAwasdegradedbyacidhydrolysis,utilizing
HCl at pH 3.8, 100◦C, for diﬀerent time periods. Each
product was isolated by ethanol precipitation, followed by
repeated washing with isopropanol and centrifugation. The
precipitate was dissolved in water (1% solution), and the
spray dried. SEC-MALS analysis was performed with the
Agilent 1100 Series chromatography system (Santa Clara,
CA, USA) equipped with the following column system: PL
aquagel-OH Mix and PL aquagel-OH 30 (300 × 7.5mm,
8μm; Polymer Laboratories). The eluent (0.1M sodium
phosphate buﬀer pH 7.5) was monitored using a DAWN-
EOS multiangle laser light scattering photometer (18-angle,
Wyatt Technologies Corporation) and refractive index detec-
tor Optilab rEX (Wyatt Technologies Corporation). Data
acquisition and MW calculations were performed using
ASTRA V software, Version 5.3.2.15. The ﬂow rate of the
mobile phase was maintained at 0.8mL/min. The speciﬁc
refractive index increment (dn/dc) of 0.155mg/mL was used
for sodium HA. SEC-MALS analysis showed both MW
and MW distribution [22]. The normalized light scattering
chromatograms with depicted MW (molecular mass in the
ﬁgure legend) distributions are shown in Figure 1.N o n e
of the samples contained HA oligomers (HA chains with
molar mass below 10kDa). The MW distributions were
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Figure 1: Light scattering chromatograms (lines) and molar mass
versus elution time plot (symbols) from SEC-MALS analysis for
52kDa HA preparation (dashed line,
￿), 250kDa HA preparation
(dotted line,  ), and 970kDa preparation (solid line,
￿).
very narrow: LMW HA with 52000g/mol (52kDa) showed
MW/Mn1.14,middle-size HAwith250000g/mol(250kDa)
showed MW/Mn 1.35, and HMW HA with 970000g/mol
(970kDa)showed MW/Mn1.34.Thepresenceofendotoxins
was tested using the PyroGene Recombinant Factor C
Endotoxin Detection System (Cambrex, USA), which did
not detect any signiﬁcant amount of endotoxin (less than
0.01EU/mL).StocksolutionsofHApr epa ra tion s(1m g/m L)
were prepared fresh in HBSS.
2.2. Materials. Unless otherwise stated all other reagents
were purchased from Sigma-Aldrich and were p.a. grade
and higher (USA). The stock solution of 10mM lumi-
nol (5-amino-2,3-dihydro-1,4-phthalazinedione) (Invitro-
gen, USA) was prepared in 0.2M sodium borate buﬀer, pH
9.0(1.24g ofH3BO3 and 7,63gofNa2B4O7·10H2Oin1lit er
of redistilled water). Phorbol 12-myristate 13-acetate (PMA)
was dissolved in dimethyl sulfoxide to obtain 3.25μmol/mL
stock solution. OZP were prepared by opsonisation of
zymosan A from Saccharomyces cerevisie by human serum
to obtain 5mg/mL stock solution, as described previously
[10]. Rice starch grains (10mg /mL, Amylum oryzae, a local
pharmacy) were prepared in Hanks balanced salt solution
(HBSS), pH 7.4.
2.3. Blood Samples Preparation and Experimental Layout of
the Incubation of Samples with HA. Blood samples were
obtained from healthy volunteers who had given informed
consent. Whole blood was diluted 1:2 (vol/vol) with RPMI
(PAN, Germany). The stock solutions of diﬀerent MW HA
(52; 250 and 970kDa) were added to the diluted blood
to obtain ﬁnal concentrations of 100μg/mL and 10μg/mL.
The concentrations were selected in order to be on the
lower limit of the range of concentrations used by other
authors [15–20, 23–27]. The lower concentration of HA
10μg/mL was, in our preliminary experiment, shown to
be on the border of having any signiﬁcant eﬀect on bloodMediators of Inﬂammation 3
phagocytes. A concentration of 1μg/mL, which is higher
than the physiological concentration in human blood [7,
28], did not possess any eﬀect on blood phagocyte ROS
production or degranulation according to our preliminary
experiments on a limited number of samples (data not
shown). Further, selected samples were mixed with collagen
(ﬁnal concentration 0.16mg/mL; Ultrapure collagen solu-
tion from bovine skin, Sigma-Aldrich), together with HA.
HBSS was used instead of HA or collagen as a control,
to adjust the same reaction volume for all samples. To
determine the eﬀects of HA on the oxidative burst of blood
phagocytes, the ROS production was measured immediately
or after 1.5h incubation at 37◦C, prior to determining their
oxidative burst. To determine the eﬀects of HA on PMNL
degranulation,thesurface expressionofthereceptorsspeciﬁc
f o rp a r t i c u l a rg r a n u l e sw a sd e t e r m i n e d3 0m i n u t e sa n d9 0
minutes after additionof HA. To determine the eﬀectsof HA
on TNF-α production, the samples were incubated for 2.5
and 6h with HA.The time points were selected based onour
previous studies [9, 29].
2.4. ROS Production (Oxidative Burst) Determination by
Chemiluminescence(CL). Luminolampliﬁedchemilumines-
cence (CL) was measured using a microplate luminometer
Orion II(Berthold DetectionSystemGmbH, Germany). The
principle of the method is based on luminol interaction
with phagocyte-derived ROS, which results in large, mea-
surable amounts of light [10]. Brieﬂy, the reaction mixture
consisted of 100μl of diluted blood, the tested substances
(HA, collagen, or an appropriate amount of buﬀer), 1mM
luminol,andone oftheactivators(ﬁnal concentrationsPMA
−97.6μg/mL, OZP −0.4mg/mL, or starch 1mg/mL). The
assays were run in duplicates. Spontaneous CL measure-
ments in samples containing 100μl of diluted blood and all
othersubstances, butnone ofthe activators, were includedin
eachassay. The CLemission wasfollowed for60min at37◦C.
The integral value of the CL reaction, which represents the
total ROS production by blood phagocytes, was evaluated,
and ﬁnal data were recalculated as a percentage of the
untreated control (100%).
2.5. Determination of PMNL Degranulation Based on Surface
Expression of Granule-Speciﬁc Receptors. Following receptors
which surface expression increases signiﬁcantly upon phago-
cyte degranulation were selected: complement receptors 1
(CD35), mostly stored in secretory vesicles, complement
receptors 3 (CD11b), stored both in speciﬁc and gelatinase
granules, and CD66, stored primarily in speciﬁc granules
[11, 13, 30]. Diluted blood was incubated with HA of
diﬀerent MW in concentrations of 100μg/mL and 10μg/mL,
and in the absence and presence of collagen (as described
above), at 37◦C for 30 and 120 minutes. Next, samples were
incubated with mouse anti-CD66b-FITC (BD Biosciences,
USA), mouse anti-CD35-FITC (clone E11, Ancell Cor-
poration, USA), mouse anti-CD11b-FITC (clone ICRF44)
(Ancell Corporation), or appropriate isotype controls (BD
Biosciences and Ancell Corporation, USA) for 15 minutes
at room temperature (RT), then ﬁxed by 4% formaldehyde
in PBS for 15 minutes at RT, as described previously [29].
Red blood cells were lysed using distilled water for the
subsequent 10 minutes at RT. After centrifugation (300g,
7 minutes), the remaining cells were resuspended in cold
PBS and kept on ice until the assessment of ﬂuorescence by
ﬂowcytometerFACSCalibur(BDBiosciences).Tenthousand
granulocytes, selected on the basis of their typical scattering
characteristics, were analyzed. The geometric mean of the
relative ﬂuorescence unit was quantiﬁed, and ﬁnal data were
recalculated as a percentage of the untreated control (100%).
2.6. Detection of Proinﬂammatory Cytokine TNF-α by ELISA.
To determine TNF-α production, diluted blood was incu-
bated with HA of a diﬀerent MW in concentrations of
100μg/mL and 10μg/mL, and in the absence and presence
of collagen (as described above), at 37◦Cf o r2 . 5ha n d6h .
After centrifugation (300g, 10 minutes, RT), supernatant
was obtained and TNF-α concentrations in the supernatant
were detected by ELISA, according to the manufacturer’s
instructions for TNF-α DuoSet ELISA Development System
(R&D Systems, Inc., USA). The absorbance was measured
at 450nm against a reference wavelength of 620nm, using
a microtiter plate reader (SLT Rainbow spectrophotometer,
Tecan, Carlsheim, Germany). The results were recalculated
to pg/mL, and ﬁnal data were expressed as a percentage of
untreated control (100%).
2.7. Statistical Analysis of Data. At least four independent
repetitions were performed for each experimental setup. All
data are reported as a percentage of the control without HA,
and all particular values are displayed by means of diﬀerent
symbols together with the median value displayed as a
bold line. Nonparametric Friedman ANOVA(StatSoft,USA)
was applied to compare diﬀerences among the control and
treated groups. A P value ≤ .05 was considered signiﬁcant:
(∗) statistical signiﬁcance to control, (#) statistical signiﬁ-
cancetosampleincubatedwith52kDaHA,and($)statistical
signiﬁcance between samples incubated with 250kDa and
970kDa HA.
3.Results
3.1. Eﬀects of Diﬀerent MW HA on Blood Phagocyte ROS
Production. The eﬀects of diﬀerent MW HA (100μg/mL) on
blood phagocytes were tested in samples containing diluted
whole blood and diluted whole blood with the addition of
collagen. All MWs of HA signiﬁcantly stimulated the spon-
taneous production of ROS by human whole blood, with
LMW HA having a signiﬁcantly higher eﬀect, middle-sized
MW HA having a signiﬁcantly smaller eﬀect, and HMW
HA having the lowest stimulatory eﬀect (Figure 2(a)). The
stimulatory potentialofall MWHAwas exhausted after1.5h
incubation, with signiﬁcantly increased ROS production
only in samples with middle and high MW HA. In the pres-
ence of collagen, all MW HA stimulated spontaneous ROS
production without a signiﬁcant diﬀerence among MW HA
measuredwithoutpreincubation(Figure 2(b)).Interestingly,
spontaneous ROS production was still signiﬁcantly higher in4 Mediators of Inﬂammation
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Figure 2: Eﬀect of diﬀerent MW HA (100μg/mL) on spontaneous (a, b), PMA-activated (c, d), OZP-activated (e, f), and starch-activated
(g, h) ROS production measured in diluted whole blood by luminol-enhanced chemiluminescence in absence (a, c, e, g) and presence of
collagen (0.16mg/mL) (b, d, f, h), immediately or after 1.5h pre-incubation after addition of HA. The bold line represents the median,
and data points from parallel measurements are presented by the same symbol. Statistically signiﬁcant diﬀerences among diﬀerent groups
(P<. 05) are marked by diﬀerent symbols: (∗) statistical signiﬁcance to control, (#) statistical signiﬁcance to sample incubated with 52kDa
HA, and ($) statistical signiﬁcance between samples incubated with 250kDa and 970kDa HA.
samplescontainingdiﬀerentMWHA,whencomparedtothe
control, after pre-incubation with the most potent eﬀect of
HMW HA.
Phagocytes can be stimulated in the presence of HA
by various activators to cause the HA potential to cos-
timulate or to inhibit blood phagocyte reaction to these
activators. Among these activators are OZP, which activate
an oxidative burst of phagocytes by binding to the opsonine
receptors. This induces a signal transduction that leads to
the activation of NADPH oxidase, the key enzyme of the
oxidative burst. Starch-mediated activation is dependent on
surface receptors recognizing glucan and other types of
polysaccharide structures. In contrast, soluble stimuli such
as phorbols directly lead to the stimulation of signaling
molecules,includingproteinkinaseCinvolvedinthesesignal
transduction pathways [10]. All these selected activators
PMA, OZP, and starch grains induced a signiﬁcant increase
in CL (data not shown). Both LMW HA and middle-
sized MW HA increased PMA-activated ROS production, in
contrast to HMW HA, which signiﬁcantly decreased PMA-
activated ROS production (Figure 2(c)). Similarly, LMW
HA and middle-sized HA signiﬁcantly potentiated PMA-
activated ROS production, compared to the control and
HMW HA samples after 1.5h pre-incubation (Figure 2(c)).
Interestingly, in the presence of collagen, both middle-
s i z e dH Aa n dH M WH Ad e c r e a s e dP M A - a c t i v a t e dR O S
production, which was signiﬁcant in samples measured
without pre-incubation (Figure 2(d)). LWM HA did not
aﬀect PMA-activated ROS production either in samples
measured immediately and after 1.5h pre-incubation.
Subsequently, the modulation of OZP-activated ROS
production by HA of diﬀerent MW was evaluated. OZP-
activatedROSproductionwasslightly,however,signiﬁcantly,
potentiated by LMW HA, in contrast to the reduction of
OZP-activated ROS production by middle-sized and HMW
HA (Figure 2(e)). The reduction eﬀect of HMW HA was
also signiﬁcant after 1.5h pre-incubation. In the presence
of collagen, all MW HA signiﬁcantly decreased OZP-
activated ROS productionin samples measured without pre-
incubation (Figure 2(f)). No MW HA signiﬁcantly modiﬁed
OZP-activated ROS production, when compared to the
control after 1.5h pre-incubation.
Finally, the eﬀects of HA of diﬀerent MW on starch-
activated ROS production were determined. All tested sam-
ples of HA revealed a stimulatory eﬀect on starch-activated
ROS production, determined both with and without 1.5h
pre-incubation (Figure 2(g)). Signiﬁcantly, LMW HA was
revealed to have the highest potency to stimulate starch-
activated ROS production, followed by middle-sized MW
HA, and ﬁnally by HMW HA, which had the lowest potency
insampleswithoutpre-incubation.Incontrast,astimulatory
eﬀect was observed in the presence of collagen only with
samplesmeasuredafterpre-incubation,anditwassigniﬁcant
only for middle-sized and HMW HA (Figure 2(h)).
To further evaluate the eﬀects of diﬀerent MW HA
on human blood phagocytes ROS production, particularly
the controversial eﬀects on OZP and starch-activated ROS
production, subsequent tests were performed with a lower
concentrationofHA10μg/mL.Onlymiddle-sizedHAinthis
lower concentration induced spontaneous ROS productionMediators of Inﬂammation 5
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Figure 3:Eﬀect of diﬀerent MWHA (10μg/mL)onspontaneous(a),OZP-activated (b),and-starch activated (c)ROS production measured
in diluted whole blood by luminol-enhanced chemiluminescence, immediately or after 1.5h pre-incubation after addition of HA. The bold
linerepresents themedian, anddata pointsfromparallelmeasurementsarepresented by thesamesymbol.Statisticallysigniﬁcantdiﬀerences
amongdiﬀerent groups (P<. 05) are marked by diﬀerent symbols: (∗) statistical signiﬁcance to control, (#) statistical signiﬁcance to sample
incubated with 52kDa HA, and ($) statistical signiﬁcance between samples incubated with 250kDa and 970kDa HA.
(Figure 3(a)). In contrast, all tested MW HA induced
spontaneous ROS production in samples pre-incubated for
1.5h. Interestingly, in contrast to data obtained with higher
HA concentrations, OZP-activated ROS production was not
signiﬁcantly modulated in samples measured without pre-
incubation and was even potentiated in samples measured
after 1.5h pre-incubation (Figure 3(b)). Similarly, starch-
activated ROS production was increased by all tested MW
HA, with the highest potency of HMW HA in samples
measured after 1.5h pre-incubation (Figure 3(c)).
3.2. Expression of Surface Receptors—Degranulation. The
eﬀectofHA(100μg/mL) onthedegranulation ofphagocytes
wasdetermined on thebasis ofthechanges ofsurface expres-
sion of receptors that are primarily stored in phagocytes
granules.
All MW HA induced an increase in CD11b expression
after 120 minutes incubation periods, independent of the
presence of collagen (Figures 4(a) and 4(b)). Interestingly,
this eﬀect was strongly dependent on MW HA, and signif-
icantly highest for LMW HA, lower for middle-sized MW
HA, and lowest for HMW HA, in both the absence and
presence of collagen (Figures 4(a) and 4(b)) .T h ei n c r e a s ei n
CD11b surface expression was already observed after 30 min
ofincubationinboth the absence and presence of collagen—
however, without any signiﬁcant diﬀerences among MW of
HA (data not shown).
AllMWHAinducedanincreaseinCD35expressionafter
incubation periods of both 30 minutes (data not shown)
and 120 minutes (Figure 4(c)), which was not signiﬁcantly
dependent on MW HA. The eﬀect on CD35 expression was
similar in the presence of collagen; the most potent eﬀect
was observed with LMW HA in samples incubated for 120
minutes (Figure 4(d)).
Similarly, all MW HA induced an increase in CD66b
expression after incubation periods of both 30 minutes
(data not shown) and 120 minutes (Figures 4(e) and 4(f)).
This eﬀect was again strongly dependent on MW HA and
signiﬁcantly highest for LMW HA, lower for middle-sized
MW HA, and lowest for HMW HA, in both the absence and
presence of collagen (Figures 4(e) and 4(f)).
We also evaluated the eﬀect of the lower HA concentra-
tion of 10μg/mL. Interestingly, none of the tested MW HA
induced any signiﬁcant increased expression of CD11b and
CD35, either after 30 minutes or 120 minutes incubation
(data not shown). The only signiﬁcant eﬀects were observed
while evaluatingCD66bsurface expression after 120 minutes
of incubation. In this case a slight, however, signiﬁcant,
expression of CD66b was induced by 250kDa HA (median
145%, max 165%, min 108%) and 970kDa HA (median
129%, max 151%, min 109%).
3.3. Production of Inﬂammatory Cytokine TNF-α. TNF-α
production by whole blood in response to diﬀerent MW HA
was determined as a marker ofthe overallactivation ofblood
leukocytes to produce inﬂammatory mediators. All MW HA
(100μg/mL) induced production of TNF-α,b o t ha f t e r2 . 5h
and 6h (Figures 5(a) and 5(b)). Interestingly, this eﬀect was
strongly dependent on MW HA, and signiﬁcantly highest
for LMW HA, lower for middle-sized MW HA, and lowest
for HMW HA, in both the absence and presence of collagen
(Figures 5(a) and 5(b)). The eﬀect of diﬀerent MW was less
signiﬁcant in the presence of collagen after 6h incubation
(Figure 5(b)). Interestingly, a signiﬁcant increase in TNF-α
production was also observed with a lower concentration
10μg/mL after 6h incubation (Figure 5(c)).
4.Discussion
HA preparations of all tested MW induced the complex
activation of blood phagocytes, with LMW having the
highest potency, middle-sized MW HA having the next
highest potency, and HMW HA having the lowest potency.
The modulation of phagocyte activation by OZP, starch, and
PMA was not generally dependent on MW of HA; however,
it was modiﬁed by the presence of collagen.6 Mediators of Inﬂammation
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Figure 4: Eﬀect of diﬀerent MW HA (100μg/mL) on the surface expression of CD11b (a, b), CD35 (c, d), and CD66b (e, f), determined
after incubation for 30 minutes or 120 minutes after addition of HA in absence (a, c, e) and presence of collagen (0.16mg/mL) (b, d, f).
The bold line represents the median, and data points from parallel measurements are presented by the same symbol. Statistically signiﬁcant
diﬀerences amongdiﬀerent groups (P<. 05)aremarkedby diﬀerent symbols:(∗) statisticalsigniﬁcancetocontrol,(#)statisticalsigniﬁcance
to sample incubated with 52kDa HA, and ($) statistical signiﬁcance between samples incubated with 250kDa and 970kDa HA.
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Figure 5: Eﬀect of diﬀerent MW HA (100μg/mL—a, b and 10μg/mL—c) on TNF-α production determined in absence and presence
of collagen (0.16mg/mL) 2.5h (a) and 6h (b, c) after addition of HA. The bold line represents the median, and data points from parallel
measurementsarepresented bythesamesymbol.Statisticallysigniﬁcantdiﬀerences amongdiﬀerentgroups(P<. 05)aremarkedbydiﬀerent
symbols:(∗) statistical signiﬁcanceto control, (#) statistical signiﬁcanceto sample incubated with 52kDa HA, and ($) statistical signiﬁcance
between samples incubated with 250kDa and 970kDa HA.Mediators of Inﬂammation 7
Interestingly, all MW HA stimulated spontaneous pro-
duction of ROS production, with the most signiﬁcant eﬀect
observedwith LMWHA.The increased ROSproductionwas
accompanied by the increase in CD11b, CD35, and CD66
surface expression, a marker of degranulation, and produc-
tion of TNF-α. Correspondingly to our study, a signiﬁcant
increase in CD11b expression on PMNL induced by both
L M WH Aa n dH M WH A( 1 0 0 μg/mL) after incubation in
whole blood has been observed by Krasi´ nski et al. [27].
Similarly to our observation of the TNF-α induction, IL-
6 and MCP1 were produced by isolated peripheral blood
mononuclear cells in response to LWM HA but not HMW
HA [14]. Moreover, these authors showed involvement of
HA receptor CD44 in this process employing anti-CD44
inhibition antibody that inhibited the response of cell to
LMWHA.Inourstudy,wealsoevaluatedtheroleofCD44in
the described eﬀects by employing anti-CD44 antibody with
a suggested inhibitory eﬀect (puriﬁed anti-mouse/human
CD44 Antibody, clone IM7, Biolegend, USA). Contrary to
our expectations, the application of this antibody induced
signiﬁcant dose-dependent activation of blood phagocytes
(data not shown). An appropriate isotype control did not
show any signiﬁcant eﬀect. This discrepancy could account
fordirectactivationofCD44receptorbyanti-CD44antibody
in a complex system as is whole blood.
Next, we focused on the modulation of blood phagocyte
response to other activators by HA of diﬀerent MW. HA of
all MW mostly inhibit the response of blood phagocytes to
soluble activator PMA. It could be speculated that HA of
diﬀerent MW can inhibit the binding of soluble stimuli to
the phagocyte surface and thus can reduce PMA-induced
ROS production. In a similar model, Krasi´ nski et al. also
found a signiﬁcant reduction of phagocyte ROS production
in response to soluble activators f-Met-Leu-Phe and PMA
by HMW HA (100–500μg/mL) [27]. Furthermore, various
authors in studies employing the isolated phagocytes found
suppression of phagocyte responses to PMA, liposacharide,
and f-Met-Leu-Phe by HA of various MW in a wide range
of concentrations [17, 24–26]. In the case of the OZP-
activated ROS production, which is dependent primarily on
the binding of OZP to cell surface opsonine receptors, all
MWs of HA mostly inhibited the activation. This suggests
the inhibition of the interaction among OZP and phagocytes
receptors recognizing OZP by HA independent of HA
MW. In contrast, in the case of the starch-activated ROS
production, which is primarily dependent on the binding
of starch grains to surface receptors recognizing glucan and
other types of polysaccharide structures, HA preparations
showed activation potential. Previously, employing hep-
arinized human whole blood as a model system, both HMW
HA (2MDa) and middle-size MW HA (0.2MDa) stimu-
lated particle stimulated phagocyte ROS production [23].
Various other studies employing isolated blood phagocytes
in a less complex environment than whole blood brought
inconclusiveresults.TheyshowedHA-mediatedpotentiation
[15, 19, 20, 23, 31], HA-mediated inhibition [15–17], or
even a lack of HA eﬀect [16, 18] on the activation of blood
phagocytes by particular stimuli or the phagocytosis of both
unopsonised and opsonized particles or bacteria.
Controversial reports about HA eﬀects on phagocytes
could account for several discrepancies. One of the reasons
could be the employment of a diﬀerent range of HA
concentrations. Some of thesestudies showed that thehigher
concentrations of HA possess inhibitory eﬀects, in contrast
to lower concentrations which possess stimulatory eﬀects
[15, 16, 23]. However, comparing the above-cited studies,
the inhibitory concentrations, the concentrations without
eﬀect, and the concentrations with stimulatory eﬀects are
overlapping. In our study, we employed HA concentrations
that were signiﬁcantly higher compared to the physiological
HA concentrations in blood (10 and 100μg/mL) [7, 28].
However,theemployedconcentrationscouldbetheoretically
reached locally after the adhesion ofphagocytesonto the gly-
cocalyxofendothelialcellsandafterdiapedesisofphagocytes
in the tissues. Of interest is also the comparison of employed
concentrations of diﬀerent HA preparations expressed as
moles per volume when 52kDa HA was 1.92 × 10
−6 mol/l,
250kDa Ha was 0.40 × 10
−6 mol/l, and 970kDa was 0.10 ×
10
−6 mol/l for the higher tested concentration (100μg/mL).
Thus, from this perspective, the concentration of LMW HA
testedinthis studywas morethanone-orderhigher thanthat
used for HMW HA.
Another reason for the inconsistent results observed by
various authors could be diﬀerences in the purity of HA
MW, including the presence of shortened HA polymers. We
employed HAwith precisely deﬁnedMW and polydispersity.
The deﬁnition of low, middle, and high MW HA is broad
and various authors employed HA of diﬀerent MW as
LMW, middle-size, and HMW HA. Compared to our study,
particularly MW of HMW HA could be signiﬁcantly higher
reaching 3-4MDa. Since our data showed the signiﬁcance
of MW in the direct activation of blood phagocytes by HA,
we can suggest that these diﬀerences among various authors
can also contribute to the inconsistent results obtained by
these authors. However, we did not observe any signiﬁcant
eﬀect of MW on the modulation of phagocyte response to
OZP or starch. Similarly to our study, the same eﬀects on
blood phagocyte activation by particular stimuli have been
reported fora wide range ofHA MWfrom HMWto middle-
size MW by Hakansson and Venge [31]. In contrast, Tamoto
et al. found that HA (0.5–5mg/mL) inhibited OZP and
polystyrene latex particle phagocytosis when investigating
guinea pig phagocytes in a dose- and MW-dependent
manner [17].
The eﬀect of HA on blood phagocytes was tested
both in diluted whole blood and in diluted whole blood
with the addition of collagen. The presence of collagen
should partly mimic the pathological conditions within
tissues where HA is in a complex with other components
of an extracellular matrix. The presence of collagen did
not signiﬁcantly modulate the eﬀect of diﬀerent MW HA
except that HA potentiated starch-activated ROS production
particularly when samples were coincubated with collagen.
This suggests that the presence of HA increased the ability
of blood phagocytes to interact with starch, and collagen
potentiates these eﬀects. This phenomenon is supported by
theobservationsofHakanssonandVengewhosuggestedthat
ﬁbronectin, another principal molecule of the extracellular8 Mediators of Inﬂammation
matrix, is key for HA stimulatory eﬀects on phagocytes,
particularly HA-mediated stimulation of PMN migration
[31, 32].
Interestingly, our ﬁndings presented herein are in direct
contrast with our previous ﬁndings when testing the eﬀects
of the same HA preparations on various mouse macrophage
cell lines [21]. In that case, we did not observe any
signiﬁcant activation of mouse macrophages, either alone
or in combination with costimulators. This suggests that
diﬀerent mechanisms are involved in the activation of
blood phagocytes in the complex environment of whole
blood. Previously tested macrophage cell lines are highly
sensitive to stimulation by any bacterial contaminations or
inﬂammatory mediators, which suggeststhespeciﬁcity ofthe
eﬀects observed herein to HA preparations not induced by
other undetected contaminations.
On thewhole, all testedMW HApreparations stimulated
the complex activation of blood phagocytes that is directly
related to host defense against pathogens [8, 33], partic-
ularly pathogens expressing HA capsule. However, under
pathological conditions of “sterile” inﬂammation in the
absence of a pathogen, the ROS overwhelmingly produced
by activated phagocytes could signiﬁcantly contribute to
the damage of the surrounding tissue. The degranulation
accompanied by the increase in surface receptor expression
is directly associated with the interaction of phagocytes with
endothelium. Finally, the resulting proinﬂammatory poten-
tial of HA in blood, particularly LMW HA, is supported by a
signiﬁcantinductionofTNF-α,oneofthekeycytokineinthe
developmentofinﬂammatory reactions. Thus, the activation
of blood phagocytes by HA, particularly by LMW HA,
could signiﬁcantly contribute to pathological inﬂammatory
processes.
5.Conclusions
Our ﬁndings provide new information about the complex
activation of blood phagocytes by HA of diﬀerent MW,
which signiﬁcantly contributes to our understanding of the
regulation of inﬂammatory processes by HA. In contrast
to other studies, we used highly puriﬁed HA of a phar-
macological grade with a low polydispersity index. Data
support the current view on LMW HAas a proinﬂammatory
agent with a strong potency for activating blood phagocytes.
However, since all the tested HA of diﬀerent MW induced
the complex activation of blood phagocytes, the data did
not conﬁrm the eﬀects of HMW as an anti-inﬂammatory
agent inhibiting blood phagocyte activation. However, more
research isneeded,employinghighlypuriﬁedHAofprecisely
deﬁnedMW,tofullyelucidatetheunderlying mechanisms of
the role of HA of diﬀerent MW in inﬂammatory processes.
Abbreviations
HA: Hyaluronan
HBSS: Hanks balanced salt solution
HMW: High molecular weight
LMW: Low molecular weight
OZP: Opsonized zymosan particles
PMA: Phorbol 12-myristate 13-acetate
PMNL: Polymorphonuclear leukocyte
ROS: Reactive oxygen species
TNF-α: Tumor necrosis factor-α.
Acknowledgments
This study was supported by a Grant from the Czech
Science Foundation, no. 305/08/1704, and the research
plansAV0Z50040507andAV0Z50040702.Theauthorsthank
Lenka Vystrcilova for her excellent technical assistance and
Dr. Martina Hermannova for the excellent preparation and
analysis of HA samples.
References
[1] P. W. Noble and D. Jiang, “Matrix regulation of lung injury,
inﬂammation, and repair: the role of innate immunity,”
Proceedings of the American Thoracic Society,v o l .3 ,n o .5 ,p p .
401–404, 2006.
[ 2 ]R .S t e r n ,A .A .A s a r i ,a n dK .N .S u g a h a r a ,“ H y a l u r o n a n
fragments: an information-rich system,” European Journal of
Cell Biology, vol. 85, no. 8, pp. 699–715, 2006.
[3] K. M. Stuhlmeier, “Aspects of the biology of hyaluronan, a
largely neglected but extremely versatile molecule,” Wiener
Medizinische Wochenschrift, vol. 156, no. 21-22, pp. 563–568,
2006.
[4] E. Pur´ ea n dC .A .C u ﬀ,“ Ac r u c i a lr o l ef o rC D 4 4i n
inﬂammation,”Trends in Molecular Medicine,v o l .7 ,n o .5 ,p p .
213–221, 2001.
[ 5 ]K .R .T a y l o r ,J .M .T r o w b r i d g e ,J .A .R u d i s i l l ,C .C .T e r m e e r ,J .
C. Simon, and R. L. Gallo, “Hyaluronan fragments stimulate
endothelial recognition of injury through TLR4,” Journal of
Biological Chemistry, vol. 279, no. 17, pp. 17079–17084, 2004.
[ 6 ]B .M .T e s a r ,D .J i a n g ,J .L i a n g ,S .M .P a l m e r ,P .W .N o b l e ,
and D. R. Goldstein, “The role of hyaluronan degradation
products as innate alloimmune agonists,” American Journal of
Transplantation, vol. 6, no. 11, pp. 2622–2635, 2006.
[7] T. C. Laurent, I. M. Dahl, L. B. Dahl et al., “The catabolic fate
of hyaluronic acid,” Connective Tissue Research,v o l .1 5 ,n o .1 -
2, pp. 33–41, 1986.
[ 8 ]D .C .D a l e ,L .B o x e r ,a n dW .C o n r a dL i l e s ,“ T h ep h a g o c y t e s :
neutrophils and monocytes,” Blood, vol. 112, no. 4, pp. 935–
945, 2008.
[9] L. Gallova, L. Kubala, M. Ciz, and A. Lojek, “IL-10 does
not aﬀect oxidative burst and expression of selected surface
antigen on human blood phagocytes in vitro,” Physiological
Research, vol. 53, no. 2, pp. 199–208, 2004.
[10] M. Pavelkova and L. Kubala, “Luminol-, isoluminol- and
lucigenin-enhanced chemiluminescence of rat blood phago-
cytes stimulated with diﬀerent activators,” Luminescence,v o l .
19, no. 1, pp. 37–42, 2004.
[11] U. Gullberg, N. Bengtsson, E. B¨ u l o w ,D .G a r w i c z ,A .L i n d -
mark, and I. Olsson, “Processing and targeting of granule
proteins in human neutrophils,” Journal of Immunological
Methods, vol. 232, no. 1-2, pp. 201–210, 1999.
[12] J. Nuutila, P. Jalava-Karvinen, U. Hohenthal et al., “Com-
parison of degranulation of easily mobilizable intracellular
granulesbyhumanphagocytesinhealthysubjects andpatients
with infectious diseases,” Human Immunology, vol. 70, no. 10,
pp. 813–819, 2009.Mediators of Inﬂammation 9
[13] M. Faurschou and N. Borregaard, “Neutrophil granules and
secretory vesicles in inﬂammation,” Microbes and Infection,
vol. 5, no. 14, pp. 1317–1327, 2003.
[14] H. Yamawaki, S. Hirohata, T. Miyoshi et al., “Hyaluronan
receptors involved in cytokine induction in monocytes,”
Glycobiology, vol. 19, no. 1, pp. 83–92, 2009.
[15] L. Hakansson,R. Hallgren, and P. Venge, “Eﬀect of hyaluronic
acid on phagocytosis of opsonized latex particles,” Scandina-
vian Journal of Immunology, vol. 11, no. 6, pp. 649–653, 1980.
[ 1 6 ]E .J .P i s k o ,R .A .T u r n e r ,a n dL .P .S o d e r s t r o m ,“ I n h i b i t i o n
of neutrophil phagocytosis and enzyme release by hyaluronic
acid,” Clinical and Experimental Rheumatology,v o l .1 ,n o .1 ,
pp. 41–44, 1983.
[ 1 7 ]K .T a m o t o ,H .N o c h i ,M .T a d ae ta l . ,“ H i g h - m o l e c u l a r - w e i g h t
hyaluronic acids inhibit chemotaxis and phagocytosis but
not lysosomal enzyme release induced by receptor-mediated
stimulations in guinea pig phagocytes,” Microbiology and
Immunology, vol. 38, no. 1, pp. 73–80, 1994.
[18] K. Tamoto, M. Tada, S. Shimada, H. Nochi, and Y. Mori,
“Eﬀects of high-molecular-weight hyaluronates on the func-
tions of guinea pig polymorphonuclear leukocytes,” Seminars
in Arthritis and Rheumatism, vol. 22, no. 6, pp. 4–8, 1993.
[19] T. Ahlgren and C. Jarstrand, “Hyaluronic acid enhances
phagocytosisofhumanmonocytesinvitro,”Journal of Clinical
Immunology, vol. 4, no. 3, pp. 246–249, 1984.
[20] F. L.Moﬀat ,T .H an,Z.M.Lie tal. ,“ I n v ol v e me ntofC D 44and
the cytoskeletal linker protein ankyrin in human neutrophil
bacterial phagocytosis,”Journal ofCellular Physiology,vol.168,
no. 3, pp. 638–647, 1996.
[21] D. Krejcova, M. Pekarova, B. Safrankova, and L. Kubala,
“The eﬀect of diﬀerent molecular weight hyaluronan on
macrophage physiology,” Neuroendocrinology Letters, vol. 30,
supplement 1, pp. 106–111, 2009.
[22] S. Podzimek, M. Hermannova, H. Bilerova, Z. Bezakova,
and V. Velebny, “Solution properties of hyaluronic acid and
comparison of SEC-MALS-VIS data with oﬀ-line capillary
viscometry,” Journal of Applied Polymer Science, vol. 116, no.
5, pp. 3013–3020, 2010.
[23] L. Hakansson, R. Hallgren, and P. Venge, “Regulation of
granulocyte function by hyaluronic acid: in vitro and in vivo
eﬀects onphagocytosis,locomotion,andmetabolism,”Journal
of Clinical Investigation, vol. 66, no. 2, pp. 298–305, 1980.
[24] H. S. Lym, Y. Suh, and C. K. Park, “Eﬀects of hyaluronic acid
on the polymorphonuclear leukocyte (PMN) release of active
oxygenandprotection ofbovinecornealendothelialcellsfrom
activated PMNs,” Korean Journal of Ophthalmology, vol. 18,
no. 1, pp. 23–28, 2004.
[25] T. Yasuda, “Hyaluronan inhibits cytokine production by
lipopolysaccharide-stimulated U937 macrophages through
down-regulation of NF-κBv i aI C A M - 1 , ”Inﬂammation
Research, vol. 56, no. 6, pp. 246–253, 2007.
[26] J. V. Forrester and P. C. Wilkinson, “Inhibition of leukocyte
locomotionbyhyaluronicacid,”Journal of Cell Science,v ol.48,
pp. 315–331, 1981.
[27] R. Krasi´ nski,H. Tch´ orzewski, and P. Lewkowicz, “Antioxidant
eﬀectofhyaluronanonpolymorphonuclearleukocyte-derived
reactive oxygen species is dependent on its molecular weight
and concentration and mainly involves the extracellular
space,” Postepy Hig Med Dosw, vol. 63, pp. 205–212, 2009.
[28] A. Tengblad, U. B. G. Laurent, and K. Lilja, “Concentration
and relative molecular mass of hyaluronate in lymph and
blood,”BiochemicalJournal, vol.236,no.2,pp. 521–525,1986.
[29] V. H´ ajkov´ a, A. Svobodov´ a, D. Krejˇ cov´ a et al., “Soluble
glucomannan isolated from Candida utilis primes blood
phagocytes,” CarbohydrateResearch,vol.344,no.15,pp.2036–
2041, 2009.
[30] A. K. Schr¨ oder, P. Uciechowski, D. Fleischer, and L. Rink,
“Crosslinking of CD66B on peripheral blood neutrophils
mediates the release of interleukin-8 from intracellular stor-
age,” Human Immunology, vol. 67, no. 9, pp. 676–682, 2006.
[31] L. Hakansson and P. Venge, “The molecular basis of the
hyaluronic acid-mediated stimulation of granulocyte func-
tion,” Journal of Immunology, vol. 138, no. 12, pp. 4347–4352,
1987.
[32] L. Hakansson and P. Venge, “The combined action of
hyaluronic acid and ﬁbronectin stimulates neutrophil migra-
tion,” Journal of Immunology, vol. 135, no. 4, pp. 2735–2739,
1985.
[33] S. J. Klebanoﬀ, “Myeloperoxidase: friend and foe,” Journal of
Leukocyte Biology, vol. 77, no. 5, pp. 598–625, 2005.